Adjuvant oral etoposide plus cisplatin (EoP) following sequential doxorubicin/cyclophosphamide (AC) and docetaxel (T) in early breast cancer patients with 4 or more positive lymph nodes (10 years follow-up)

✍ Scribed by Fikri Icli; Hakan Akbulut; Handan Onur; Bulent Yalcin; Ahmet Demirkazık; Filiz Çay Şenler

• Book ID: 113507284
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 132 KB
• Volume: 20
• Category: Article
• ISSN: 0960-9776
• DOI: 10.1016/j.breast.2010.09.002